Source: BIOPORTFOLIO

Epro: CROs plan to increase use of ePRO tech

CROs as well as sponsors are receptive to and plan to increase their use of ePRO electronic patient reported outcomes according to aÂsurvey publishedÂMonday from the Tufts Center for the Study of Drug Development.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Bob Gilkes's photo - CEO of Epro

CEO

Bob Gilkes

CEO Approval Rating

88/100

Read more